Inovio Pharmaceuticals Inc. (NASDAQ: INO) Stock Information | RedChip

Inovio Pharmaceuticals Inc. (NASDAQ: INO) Listen to this Section


$7.84
+0.0400 ( +0.51% ) 229.4K

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Market Data


Open


$7.84

Previous close


$7.80

Volume


229.4K

Market cap


$203.30M

Day range


$7.72 - $8.00

52 week range


$3.89 - $14.75

Insider Ownership Transactions

Total Amount Purchased: -30,273.00 | $ -237,340.32

Date Type Amount Purchased Purchaser
2024-07-01 Sale -2917.00 Sumner Michael John
2024-05-22 Sale -2917.00 Zoth Lota S.
2024-05-22 Sale -2917.00 Miller Ann Calby
2024-05-22 Sale -2917.00 Weiner David B.
2024-05-22 Sale -2917.00 DANSEY ROGER D
2024-05-22 Sale -2917.00 YARNO WENDY L
2024-05-22 Sale -2917.00 BENITO SIMON X
2024-05-22 Sale -2917.00 Shepard Jay
2024-05-16 Sale -4771.00 KIES PETER
2024-05-16 Sale -2166.00 Shepard Jay

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 13, 2024
10-q Quarterly Reports 68 Aug 08, 2024
8-k 8K-related 15 Aug 08, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 13 May 28, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.